Cited by 547Tuberculosis Research and EpidemiologyInfectious Diseases and TuberculosisHIV, TB, and STIs Epidemiology

The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.

The global prevalence of latent tuberculosis: a systematic review and meta-analysis

Open access

Cohen, Adam, Mathiasen, Victor Dahl, Schön, Thomas, Wejse, Christian·2019·European Respiratory Journal

DOI 10.1183/13993003.00655-2019

Open this paper in CoChat — free account Open PDF

Abstract

In 1999, the World Health Organization (WHO) estimated that one-third of the world's population had latent tuberculosis infection (LTBI), which was recently updated to one-fourth. However, this is still based on controversial assumptions in combination with tuberculin skin test (TST) surveys. Interferon-γ release assays (IGRAs) with a higher specificity than TST have since been widely implemented, but never used to estimate the global LTBI prevalence. We conducted a systematic review and meta-analysis of LTBI estimates based on both IGRA and TST results published between 2005 and 2018. Regional and global estimates of LTBI prevalence were calculated. Stratification was performed for low, intermediate and high TB incidence countries and a pooled estimate for each area was calculated using a random effects model. Among 3280 studies screened, we included 88 studies from 36 countries with 41 IGRA (n=67 167) and 67 TST estimates (n=284 644). The global prevalence of LTBI was 24.8% (95% CI 19.7–30.0%) and 21.2% (95% CI 17.9–24.4%), based on IGRA and a 10-mm TST cut-off, respectively. The prevalence estimates correlated well to WHO incidence rates (Rs=0.70, p<0.001). In the first study of the global prevalence of LTBI derived from both IGRA and TST surveys, we found that one-fourth of the world's population is infected. This is of relevance, as both tests, although imperfect, are used to identify individuals eligible for preventive therapy. Enhanced efforts are needed targeting the large pool of latently infected individuals, as this constitutes an enormous source of potential active tuberculosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1183/13993003.00655-2019

Cites

123 of 123 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
Elm, E. V., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007) · BMJ · doi:10.1136/bmj.39335.541782.ad · Cited by 10,766
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
Hill, N. R., Fatoba, S., Oke, J. L., Hirst, J. A., O’Callaghan, C. A., Lasserson, D. S., & Hobbs, R. F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158765 · Cited by 4,320
Global Burden of Tuberculosis
Dye, C., Scheele, S., >Dolin, P., Pathania, V. S., Raviglione, M. C., & for the WHO Global Surveillance and Monitoring Project (1999) · JAMA · doi:10.1001/jama.282.7.677 · Cited by 2,955
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
Houben, R. M. G. J., & Dodd, P. J. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002152 · Cited by 2,054
The Immune Response in Tuberculosis
O’Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,400

Show all 123 references

Research works printed but not linked: 2

Styblo, 1985, The relationship between the risk of tuberculous infection and the risk of developing infectious tuberculosis, Bull Int Union Tuberc Lung Dis, 60, 117
Murthy, 2013, PLoS One, 8, e71470

Sorted by citations

Items 301–400 of 547

Data Control and Surveillance in the Global TB Response: A Human Rights Analysis
Albrecht, K., & Citro, B. (2020) · Law Technology and Humans · doi:10.5204/lthj.v2i1.1487 · Cited by 4
Predictors of tuberculosis infection among children and adolescents with positive results of a skin test with recombinant TB allergen
Дмитриевна, Б. О., Aksenova, V., Анатольевна, Б. Л., Kudlay, D. A., & Nakonechnaya, S. L. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-16-147-154 · Cited by 3
Tuberculosis Preventive Treatment in India
Saurabh, S., & Bhardwaj, P. (2021) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_2504_20 · Cited by 3
Effective combined antiretroviral therapy provides partial immune recovery to mycobacterial antigens in vertically infected, BCG-vaccinated youth living with HIV
Castelhano, M. V., Alves, P. C. M., Macedo, V. S., Arrym, M. P., Guimarães, F., Panunto, P. C., Mazzola, T. N., Mauch, R. M., Vilela, M. M. D. S., & da Silva, M. T. N. (2022) · Tuberculosis · doi:10.1016/j.tube.2022.102170 · Cited by 3
A cohort study of the long-term outcome of latent tuberculosis infection among socially marginalized people in a low-incidence country
Stærke, N. B., Martinsen, J. T., Jensen, T. T., Weinreich, U. M., Hilberg, O., Folkvardsen, D. B., Wejse, C. M., & Fløe, A. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.02.033 · Cited by 3
Self-citation
Advantages of short-course rifamycin-based regimens for latent tuberculosis infection: an updated network meta-analysis
Peng, T., Chen, J., Chang, Y.-H., Shiang, J.-C., Lee, M., Lee, C., & Wang, J. (2022) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2022.04.025 · Cited by 3
Responding to the post-pandemic crisis: post-exposure prophylaxis for TB
Heffernan, C., Savić, R. M., Long, R., Raviglione, M. C., & Ferrara, G. (2022) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.22.0342 · Cited by 3
Indicação do tratamento da tuberculose latente: desafios identificados no sistema de notificação brasileiro, 2018-2022
Pavinati, G., de Lima, L. V., Couto, R. D. M., Alves, L. C., Vega, F. L. R., da Silva, D. A., Orti, D. G. D., Arakaki-Sánchez, D., Alves, K. B. A., Bartholomay, P., et al. (2023) · Revista de Saúde Pública do Paraná · doi:10.32811/25954482-2023v6n2.750 · Cited by 3
Tuberculose et infection par le virus de l’immunodéficience humaine : comment réduire la mortalité ?
Blanc, F. –. (2023) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2023.07.007 · Cited by 3
Tendência temporal da incidência de coinfecção tuberculose-HIV no Brasil, por macrorregião, Unidade da Federação, sexo e faixa etária, 2010-2021
de Lima, L. V., Pavinati, G., de Oliveira, R. R., Couto, R. D. M., Alves, K. B. A., & Magnabosco, G. T. (2024) · Epidemiologia e Serviços de Saúde · doi:10.1590/s2237-96222024v33e2023522.pt · Cited by 3
Diagnosis of Latent Tuberculosis Infection: Promising Antigens
Jomehpour, N., Soleimanpour, S., & Sankian, M. (2023) · Iranian Journal of Medical Microbiology · doi:10.30699/ijmm.17.5.505 · Cited by 3
Bioinformatics Study and Experimental Evaluation of miR-182, and miR-34 Expression Profiles in Tuberculosis and Lung Cancer
Alimardanian, L., Soltani, B. M., Irani, S., & Sheikhpour, M. (2024) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2023.0172 · Cited by 3
Current Challenges in the Management of Tuberculosis
Srivastava, V., & Verma, A. (2024) · Journal of Young Pharmacists · doi:10.5530/jyp.2024.16.21 · Cited by 3
Magnitude and Determinants of Latent Tuberculosis Among Inmates of Saudi Correctional Facilities: A Cross-Sectional Study
Alshowair, A., Assiri, A. M., Balfas, A. H., Alkhattabi, R., Eltegani, T. A., Altowairib, S., Almalki, A., Alharbi, E., Alotai, S., Alobaid, F. K., et al. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s472710 · Cited by 3
Abnormal skin changes and unilateral vision loss after a tuberculin skin test
Naidu, S. C., Kaplan, A., Daneman, N., Sundaram, A. N. E., & Kohly, R. P. (2021) · Canadian Medical Association Journal · doi:10.1503/cmaj.211021 · Cited by 3
Induction of Cross-Reacting Antibodies Against the COVID-19 by BCG Vaccination in the Mouse Model
Rahali, N., & Bahloul, C. (2022) · Current Microbiology · doi:10.1007/s00284-022-02971-w · Cited by 3
Pyrimidine Nucleosides Analogues as Mycobacteria Growth Inhibitors
Alexandrova, L. A., Khandazhinskaya, A. L., Matyugina, E. S., Makarov, D. A., & Kochetkov, S. N. (2022) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pamicr3ed.3.22.7 · Cited by 3
Prevalence and factors associated with latent tuberculosis infection among residents of a monastery situated in a high-TB burden area: A cross sectional study, Sikkim, IndiaPreprint
Siddiqui, M. K., Khan, S., Bhutia, R., Nair, V., Gurung, N., Yamphel, T., Dadul, P. K., Kerongi, D. S., Pradhan, J., Khati, K., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1872450/v1 · Cited by 3
Incidence of tubercular lymphadenitis in cases of cervical lymphadenopathy by fine needle aspiration cytology-A single center study.
Chand, V., Katara, A., Chand, S., Vishwakarma, S., Chaudhry, V., & Chandra, H. (2025) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2025.108125 · Cited by 2
Evaluation of cancer patients receiving concurrent chemotherapy and antituberculosis treatment: Review and case series of a single-center experience
Erdur, E., & Yıldırım, Ö. A. (2022) · Journal of Surgery and Medicine · doi:10.28982/josam.1015461 · Cited by 2
Pharmacokinetics of standard versus high-dose rifampin for tuberculosis preventive treatment: A sub-study of the 2R2 randomized controlled trial
Gafar, F., Yunivita, V., Fregonese, F., Apriani, L., Aarnoutse, R. E., Ruslami, R., & Menzies, D. (2024) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2024.107197 · Cited by 2
Exploring expression levels of the cGAS-STING pathway genes in peripheral blood mononuclear cells of spinal tuberculosis patients
Peng, X., Pu, F., Zhou, F., Dai, X., Xu, F., Wang, J., Feng, J. B., & Xia, P. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09815-x · Cited by 2
Epidemiology of Latent Tuberculosis in Moroccan Healthcare Workers: Prevalence Patterns and Predisposing Factors
Boucaid, A., Zegmout, A., Bhairis, M., Amraoui, M., Laaraje, A., Kabiri, E. H., & Rhorfi, I. A. (2024) · Cureus · doi:10.7759/cureus.75740 · Cited by 2
The Utility of Interferon‐γ Release Assays in the Diagnosis of Tuberculosis in Patients With Cancer
Batista, M. V., Sassine, J., Khawaja, F., Kulkarni, P. A., Angelidakis, G., Kmeid, J., Chaer, F. E., Ariza‐Heredia, E., Graviss, E. A., Mulanovich, V. E., et al. (2024) · Transplant Infectious Disease · doi:10.1111/tid.14428 · Cited by 2
Enhancing Antituberculosis Treatment Nanoparticles Encapsulated with Catalase and Levofloxacin Under Ultrasound Stimulation: A 3D Spheroid Study
Guo, J., Qiu, Y., Hu, C., Cao, Y., Li, D., & Du, Y. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00748 · Cited by 2
Preliminary evaluation of a new prototype interferon-gamma release assay for the detection of Mycobacterium tuberculosis–specific T-cell responses in patients with tuberculosis
Ibrahimová, M., Doležalová, K., Bača, Ľ., Sukholytka, M., Grage‐Griebenow, E., Zapf, D., Saschenbrecker, S., Herbst, V., Kopecká, E., & Vašáková, M. (2025) · Folia Microbiologica · doi:10.1007/s12223-025-01252-w · Cited by 2
Latent Tuberculosis Infection among Household Contacts of Tuberculosis Patients, Healthcare Workers, and Tuberculosis Patients Using QuantiFERON-tuberculosis Gold Plus and Tuberculin Skin Test in a Tertiary Care Hospital Setting Bhubaneswar, Odisha – A Cross-sectional Study
Barik, B. S., Kar, C. D., Das, S., Hussain, T., Nayak, S., Sahu, A. K., Sundaray, S., & Pati, S. (2025) · Journal of Global Infectious Diseases · doi:10.4103/jgid.jgid_78_24 · Cited by 2
Prevalence, Conversion and Reversion of Tuberculosis Infection Among Healthcare Workers of Tertiary Care Centres in Puducherry, India: A Prospective Cohort Study
Subramanian, S., Chinnakali, P., Prakashbabu, S., Visvanadane, G. N., Rajaram, M., Viswanathan, V., Sarkar, S., & Horsburgh, C. R. (2025) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed10050141 · Cited by 2
Geospatial Distribution of Tuberculosis Incidence and Determinants of Tuberculosis Treatment Outcomes in Nzema East Municipality, Ghana
Agyapong, C. A., Parsa, A. D., Hayhoe, R. P. G., Kabir, R., & Cortnage, M. (2025) · Public Health Challenges · doi:10.1002/puh2.70108 · Cited by 2
Reliable, accessible, cost-effective, & easy (RACE) diagnostic modality: A key for elimination of tuberculosis
Singh, S., & Shrivas, A. (2025) · The Indian Journal of Medical Research · doi:10.25259/ijmr_527_2025 · Cited by 2
Mycobacterium tuberculosis infection status and associated factors among household close contacts of rifampicin-resistant pulmonary tuberculosis patients: A single-center cross-sectional study
Shi, Z., Peng, J., Li, X., Fu, X., Zou, L., Chen, Q., Huang, T., Zhou, Y., Zhu, H., Wang, Y., et al. (2025) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2025.100561 · Cited by 2
A multiplex Mtb-specific FluoroSpot assay measuring IFNγ, IL-2, and TNF-secreting cells can improve accuracy and differentiation across the tuberculosis spectrum
Folkesson, E., Foroogh, F., Kleberg, L., Kjellgren, V., Jakobsson, M., Grunewald, L., Hellberg, J., Ryberg, J., Maher, Z., Silva, C. S., et al. (2025) · Journal of Clinical Microbiology · doi:10.1128/jcm.00894-25 · Cited by 2
The role of co-infection in the pathogenesis of acute SARS-CoV-2 infection and development of post-acute sequelae: A perspective
Henrich, T. J., Montgomery, C. P., Graf, J., Ismali, N., Mohandas, S., Suthar, M. S., Brim, H., Coffin, J. M., Pagaria, A., Rivera, J. G., et al. (2025) · eLife · doi:10.7554/elife.106308 · Cited by 2
HeptaTB Dx: a diagnostic model leveraging cuproptosis-ferroptosis crosstalk for distinguishing latent from active tuberculosis
Li, L., Wang, P., Li, Z., Bai, G., Ye, Z., Yang, L., Li, Z., Sun, W., & Gong, W. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02995-25 · Cited by 2
The effect of latent Mycobacterium tuberculosis infection on ovarian reserve and pregnancy outcomes among infertile women in China
Yang, X., Chen, H., Kong, X., Lai, T., Liang, H., Chen, Z., Wu, T., Mo, M., & Li, Y. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-12424-x · Cited by 2
Stability and optimizing the treatment control of tuberculosis model via numerical approach
Farman, M. T., Amilo, D., Ghannam, M., Nisar, K. S., & Hafez, M. (2025) · Results in Control and Optimization · doi:10.1016/j.rico.2025.100650 · Cited by 2
Immunological testing and machine learning in detecting latent tuberculosis among high-risk groups (nature review)
Starshinova, A. A., Sabirova, A. R., Igor, K., Rubinstein, A., Churilov, L. P., Belyaeva, E., Anastasia, K., Sharipov, R. A., Tukfatullin, R. K., Nikolenko, N. Y., et al. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2025.1710960 · Cited by 2
Evaluation of a Fluorescence Immunoassay-Based IGRA for Latent Tuberculosis Diagnosis: A Simplified, Cost-Effective Alternative
Uddin, M. K. M., Mahmud, A. R., Rupa, A. A., Islam, A., Oishi, J. F., Ferdous, J., Nasrin, R., Rahman, S. M. M., Kabir, S., Ahmed, S., et al. (2026) · Microorganisms · doi:10.3390/microorganisms14030603 · Cited by 2
Advances in Detecting Latent Tuberculosis Infection in High-Risk Groups: from Immunodiagnostics to Machine Learning (Systematic Review)
Sabirova, A. R., Ахнафович, Ш. Р., Tukfatullin, R. K., Dovgalyuk, I. F., Kudlay, D. A., & Starshinova, A. A. (2026) · Tuberculosis and lung diseases · doi:10.58838/2075-1230-2026-104-1-100-113 · Cited by 2
Association between immune-response magnitude to tuberculosis infection tests and short-term disease risk: a prospective cohort study
Ratovoson, R., Donkeng, V. F. D., Ranaivomanana, P. P., Tagnouokam-Ngoupo, P. A., Mbougua, J. B. T., Mbouchong, V. B., Kamtchogom, V., Razafimahefa, A., Londi, E., Ramane, N. A., et al. (2026) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2026.06.011 · Cited by 2
Scaling Up Tuberculosis Preventive Treatment in the Brazilian Amazon (2016-2024): a Programmatic Report on Multi-sector Integration in Surveillance, Health Services and Academia
Pinheiro, J. D. S., de Assis, L. B. D. O., Baía-da-Silva, D. C., Oliveira, V. C., Garcia, L. S., Spener-Gomes, R., Aguiar, A. F. S., Rocha, A. C., Souza, A. B., Costa, A. G., et al. (2026) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0570-2025 · Cited by 2
Screening of latent tuberculosis Infection among healthcare students and medical doctors using tuberculin skin test
Goweda, R. A. (2021) · Family Medicine & Primary Care Review · doi:10.5114/fmpcr.2021.105908 · Cited by 2
IMMUNE RESPONSE ON THE ADMINISTRATION OF RECOMBINANT PROTEIN ANTIBODIES AG-38 KDA MYCOBACTERIUM TUBERCULOSIS AND RIFAMPICIN EX-VIVO.
Raras, T. Y. M., Fahrinda, A., Yuliati, Y., Nurhidayati, D. Y., Sujuti, H., & Prawiro, S. R. (2022) · African Journal of Infectious Diseases · doi:10.21010/ajid.v16i2.8 · Cited by 2
Exploring the role of Microbiome in Susceptibility, Treatment Response and Outcome among Tuberculosis Patients from Pakistan: study protocol for a prospective cohort study (Micro-STOP)
Shahzad, M. A., Haq, Z. U., & Andrews, S. C. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058463 · Cited by 3
Determinants of Response at 2 Months of Treatment in a Cohort of Pakistani Patients with Pulmonary Tuberculosis
Shah, S. A., Khan, A., Shahzad, M. A., Mokhtar, J. A., Harakeh, S., Kibria, Z., Mehr, A., Bano, B., Ali, A., & Yousafzai, Y. M. (2022) · Antibiotics · doi:10.3390/antibiotics11101307 · Cited by 2
Prevalence of Latent Tuberculosis Infection and its Associated Factors Among Diabetic Patients Availing Primary Health Care in Terengganu State, Malaysia
Husain, N. F., Yusoff, H. M., Hassan, N. M., & Aziz, A. A. (2023) · Oman Medical Journal · doi:10.5001/omj.2023.97 · Cited by 2
Tuberculosis
Kızıltaş, Ş., & Babalık, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-22483-6_40-1 · Cited by 2
A multi-criteria decision analysis framework that prioritizes economic policy to enhance value based health care during the COVID-19 pandemic
Antioch, K. M., Kuek, A., Pilla, J. E., & Marshall, R. (2024) · Discover Health Systems · doi:10.1007/s44250-024-00070-0 · Cited by 2
Diagnosis of latent tuberculosis infection
Bogorodskaya, E. M., & Litvinov, V. I. (2024) · Tuberculosis and socially significant diseases · doi:10.54921/2413-0346-2024-12-2-43-52 · Cited by 2
Toll-Like Receptor Genes and Risk of Latent Tuberculosis Infection in People Infected with HIV-1
Salamaikina, S., Kulabukhova, Е. I., Иванович, К. В., Khokhlova, O. N., Миронов, К. О., & Акимкин, В. Г. (2024) · Viruses · doi:10.3390/v16091371 · Cited by 2
Prevalence and Risk Factors of LTBI at Madura Boarding School as a High-Risk Congregate Setting
Ananto, M. A., Setyoningrum, R. A., & Lestari, P. (2024) · JUXTA Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga · doi:10.20473/juxta.v15i22024.76-82 · Cited by 2
Association of clinical laboratory parameters with latent tuberculosis infection among healthcare workers of primary health centers―A cross-sectional observational study
Selvavinayagam, S. T., Sankar, G., Yong, Y. K., Sankar, S., Zhang, Y., Tan, H. Y., Balakrishnan, P., Murugesan, A., Rajeshkumar, M., Frederick, A., et al. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004873 · Cited by 3
Transcriptomic signatures have a place in short-term prediction of incident tuberculosis
Wejse, C. M. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30980-4 · Cited by 2
Self-citation
Indications, Interpretation and Clinical Consequences of Tuberculin Skin Tests in Resource Limited Settings
Gopie, F. A., Hassankhan, A., Zijlmans, W. C. W. R., & Vreden, S. (2021) · Journal of Tuberculosis Research · doi:10.4236/jtr.2021.93016 · Cited by 2
Pulmonary Tuberculosis After Therapy with Anti-Tumor Necrosis Factor (TNF) for Crohn Disease: A Case Report
da Silva, D. I. C., Santos, B. H. D. O., Renosto, F. L., Watanabe, E. M., Herrerias, G. S. P., Saad-Hossne, R., Baima, J. P., & Sassaki, L. Y. (2021) · American Journal of Case Reports · doi:10.12659/ajcr.932963 · Cited by 2
Prevalence and determinants of latent tuberculosis infection among healthcare personnel in India
Vaman, R. S., Valamparampil, M. J., & Nair, S. (2021) · Journal of Patient Safety & Infection Control · doi:10.4103/jpsic.jpsic_19_21 · Cited by 2
Evaluation of cytokine levels in response to mitogen among HIV-1-infected blood cells and their relationships to the number of T cells
Imoto, S., Suzukawa, M., Takeda, K., Asari, I., Watanabe, S., Tohma, S., Nagase, T., Ohta, K., Teruya, K., & Nagai, H. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155840 · Cited by 2
Cost effectiveness analysis of single and sequential testing strategies for tuberculosis infection in adults living with HIV in the United States
Fekadu, G., Yao, J., & You, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-22721-z · Cited by 2
Prevalence of hepatitis B virus ( HBV ) and latent tuberculosis co‐infection and risk of drug‐induced liver injury across two large HBV cohorts in the United States
Wong, R. J., Rupp, L. B., Lü, M., Yang, Z., Daida, Y. G., Schmidt, M. A., Boscarino, J. A., Gordon, S. C., & Chitnis, A. S. (2023) · Journal of Viral Hepatitis · doi:10.1111/jvh.13823 · Cited by 2
Evaluation of the Pulmonary Tuberculosis Control Program
Alwi, M. K., Hasanuddin, A., Setianto, R., Azizah, F., Dewi, B. A., Dai, N. F., Hasin, A., & Syarif, J. (2023) · Jurnal Penelitian Pendidikan IPA · doi:10.29303/jppipa.v9i6.3791 · Cited by 2
Mycobacterium tuberculosis -specific T cell activation identifies individuals at high risk of tuberculosis diseasePreprint
Mpande, C. A. M., Musvosvi, M., Rozot, V., Mosito, B., Reid, T. D., Schreuder, C., Lloyd, T., Bilek, N., Huang, H., Obermoser, G., et al. (2020) · medRxiv · doi:10.1101/2020.06.26.20135665 · Cited by 2
Challenges in LTBI care in the United States identified using a nationwide TB medical consultation database
Agathis, N. T., Bhavaraju, R., Shah, V., Chen, L., Haley, C. A., Goswami, N. D., & Patrawalla, A. (2021) · Public Health Action · doi:10.5588/pha.21.0026 · Cited by 1
Feasibility study of the prevalence of latent tuberculosis infection for Māori in the Waikato region, Aotearoa New Zealand
Uruamo, S., McAllister, S. M., Scott, N., Hancox, R. J., Hayudini, R., Baxter, J., & Hill, P. C. (2022) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.13274 · Cited by 1
Safety of new tuberculosis treatment regimens and compliance with these regimens according to data from the Republic of Kazakhstan
Zhandauletova, Z., Nikishova, E. I., Мaryandyshev, А. O., Ks, S., Adenov, M. M., Ismailov, S. S., Sapieva, Z. A., Trusov, A. A., Mussabekova, G., Kasymbekova, S., et al. (2023) · Tuberculosis and lung diseases · doi:10.58838/2075-1230-2023-101-1-17-26 · Cited by 1
Cloning and Production of Antigen 85A Mycobacterium tuberculosis for Diagnostic Latent Tuberculosis: a Preliminary Study
Agus, R., Sjafaraenan, Samara, Y., & Massi, M. N. (2023) · HAYATI Journal of Biosciences · doi:10.4308/hjb.31.2.374-381 · Cited by 1
Effectiveness of Mycobacterium tuberculosis recombinant proteins-coated gold nanoparticles in improving the interferon-gamma release assay test
Jomehpour, N., Sankian, M., Soleimanpour, S., Derakhshan, M., Ghazvini, K., Pordel, S., & Moghadam, M. (2024) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2024.06.015 · Cited by 1
Evaluation of nonpolar lipid extract antigen-based enzyme-linked immunosorbent assay for the serodiagnosis of tuberculosis
Araújo, L. E., Petrilli, J. D., Oliveira, C. R., Horta, T., Estevão, P., Carvalho, F. R., Cardoso, C. A. A., Cardoso, T. M., de Ângelis, L., Montenegro, L. M. L., et al. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116560 · Cited by 1
MODELING OF THE SPREAD OF TUBERCULOSIS BY REGIONS IN UKRAINE
Boyko, N. I., & Rabotiahov, D. S. (2024) · Radio Electronics Computer Science Control · doi:10.15588/1607-3274-2024-4-4 · Cited by 1
Latent tuberculosis prevalence in healthcare workers in Laos: a cross-sectional study
Duangmixay, S., Virachith, S., Hübschen, J. M., Siphanthong, P., Suthepmany, S., Sayasone, S., & Black, A. P. (2025) · Tropical Medicine and Health · doi:10.1186/s41182-024-00677-2 · Cited by 1
Four-month clofazimine regimen for susceptible pulmonary TB: a randomized clinical trial
Shafiq, N., Kumar, A., Vohra, V., Khuller, G. K., Singh, M., Kaur, A., Gulati, N., Chopra, V., Gupta, A., Kaushal, S., et al. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaf176 · Cited by 1
Enhanced screening for tuberculosis infection among immigrants in southern New Brunswick: A cross-sectional pilot study
Shamputa, I. C., Nguyen, D., Mackenzie, H., Gaudet, D. J., Harquail, A., Barker, K., & Webster, D. (2025) · Canada Communicable Disease Report · doi:10.14745/ccdr.v51i05a03 · Cited by 1
Influence of Single-nucleotide Polymorphism of INF-γ (rs.2430561, +874 A/T) and Interleukin-10 (rs.1800896, −1082 A/G) on the Risk of Tuberculosis and Drug Resistance in Kaduna State, Nigeria
Madaki, S., Mohammed, Y., Rogo, L. D., Yusuf, M., Bala, Y. G., & Ahmad, U. A. (2025) · International Journal of Mycobacteriology · doi:10.4103/ijmy.ijmy_39_25 · Cited by 1
Evaluating the concordance, prevalence, and risk factors of latent tuberculosis infection among healthcare workers in Makkah: A comparative analysis of TST and IGRA
Almutairi, N. S. (2025) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2025.116990 · Cited by 1
Exosomal cargoes as potential biomarkers for latent tuberculosis infection: a promising frontier in diagnosis?
Chen, H., Liang, S., Li, W., Cao, T., Geng, S., & Liu, J. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120523 · Cited by 1
Epidemiological features of tuberculosis infection in a high-altitude population: a population-based, cross-sectional survey in Tibet, China
Wang, J., Pei, S., Yang, G., Nima, Q., Song, Q., Liu, X., Li, X., Chen, W., Li, T., Liu, E., et al. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1651920 · Cited by 1
Research Communication: Risk of Tuberculosis With Advanced Therapies in 20,705 Patients With Inflammatory Bowel Diseases in Low Incidence Regions—A U.S. Claims‐Based Study
Ahuja, D., Yeh, K., Patel, S. B., Park, S., Xu, R., & Singh, S. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70443 · Cited by 1
Leveraging Mycobacterium tuberculosis Rv1507A Protein for Improved Immunogenicity in Mycobacterium bovis BCG Vaccine
Naqvi, N., Alam, A., Shariq, M., Ahuja, Y., Mitra, D. K., Hasnain, S. E., & Ehtesham, N. Z. (2025) · Immunology · doi:10.1111/imm.70063 · Cited by 1
Prevalent and incident latent tuberculosis infection among healthcare workers in Taiwan: A multi-center observational study
Wu, C.-J., Lee, S. S.-J., Shu, C., Lin, S., Lee, C.-C., Huang, J.-R., Wang, T., Pan, S., Feng, J., & Chen, Y. (2025) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2025.11.006 · Cited by 1
Detection of latent tuberculosis infection and active tuberculosis among adults at risk in the Moscow region
Дмитриевна, Б. О., Smerdin, S., Tusheva, I. A., Gordeev, A. A., Kudlay, D. A., & Doktorovа, N. P. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-385 · Cited by 1
Tamoxifen inhibits histidine kinases of M. tuberculosis two-component signaling systems
Garg, A., Singh, D. P., Pandit, M., Malhotra, V., & Saini, D. K. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01880-25 · Cited by 1
The risk of latent tuberculosis infection in patients with type 2 diabetes mellitus according to the use of sodium-glucose cotransporter 2 inhibitors: A national database cohort study
Lee, C.-S., Ho, C.-H., Liao, K., Wu, Y.-C., & Shu, C. (2026) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2026.108436 · Cited by 1
Environmental-demographic determinants associated with tuberculosis prevalence in seven African countries: an aggregated dataset analysis
Haverkate, T. M. I., Brals, D., Abukaraig, E. A. B., Kapata, N., Chanda‐Kapata, P., Kirenga, B., Klinkenberg, E., Law, I., Maama-Maime, L. B., Moyo, S., et al. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.103773 · Cited by 1
Acceptance, completion, and safety of the 3HR regimen for latent tuberculosis infection: a prospective cohort study in China
Sun, Q., Zhang, K., Chen, J., Feng, L., 石柳春, Liu, S., & Liu, A. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1794409 · Cited by 1
Prevalence of latent tuberculosis infection in Malaysia: the first systematic review and meta-analysis
Wada, Y., Afolabi, H., Irekeola, A., Bello, K., Chan, Y.-A.-Y.-A., & Rahman, Z. A. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13406-3 · Cited by 1
Evaluation of subclinical tuberculosis among end-stage kidney disease patients on hemodialysis
Siripoon, T., Chancharoenthana, W., Lawpoolsri, S., Traitanon, O., Pattharanitima, P., Chaisrisiri, N., Kamolratanakul, S., Luvira, V., Phumratanaprapin, W., & Pitisuttithum, P. (2026) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2026.108978 · Cited by 1
Microbial biodiversity in the throats of pulmonary tuberculosis patients and tuberculin skin test (TST) positive and negative healthy individuals in Malaysia
Semail, N., Suraiya, S., Ramos, R. C., Mirabal, M., Carrillo-Calvet, H., Hashim, E. K. M., Sarmiento, M. E., Acosta, A., & Norazmi, M. N. (2020) · Tuberculosis · doi:10.1016/j.tube.2020.101965 · Cited by 1
What Tool for Diagnosis of Latent Tuberculosis Infection in Developing Country with Tuberculosis High Burden: Interferon Gamma Release Assays versus Tuberculin Skin Test in Burkina Faso
Djibougou, D. A., Mensah, G. I., Kientega, T., Sawadogo, L. T., Hien, H., Meda, C. Z., Bélem, A. M. G., Dabiré, R. K., Bonfoh, B., Addo, K. K., et al. (2022) · Advances in Infectious Diseases · doi:10.4236/aid.2022.124047 · Cited by 1
A Systematic Review of Prevalence and Risk Factors of Latent Tuberculosis Infection Among Medical and Nursing Students
Ismail, Z., Musa, L. H., Ithnin, M., Mohamed, N. A., Baharom, N., Ramli, S., & Pathmanathan, S. G. (2022) · Malaysian Journal of Medicine and Health Sciences · doi:10.47836/mjmhs.18.6.35 · Cited by 1
Fluoroquinolone-resistant latent tuberculosis infection: A literature review and case series of 5 patients treated with linezolid monotherapy
Baker, J. J., Nahar, R., Petroelje, B. K., Goswami, N. D., & Lardizabal, A. A. (2023) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2023.100376 · Cited by 1
Apical fibrobullous lung disease in spondyloarthritis patients with biologic DMARDs indication
Özsoy, Z., Ayan, G., Durhan, G., & Kalyoncu, U. (2023) · Lara D. Veeken · doi:10.1093/rheumatology/kead361 · Cited by 1
Tuberculin test using Indian indigenous purified-protein derivative (PPD) shows only moderate agreement with international standard PPD
Christopher, D. J., Priya, N., Shankar, D., Isaac, B. T. J., DeLuca, A. N., Sarkar, S., Babu, S. P., Samuel, P., Cattamanchi, A., Gupta, A., et al. (2023) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2023.100404 · Cited by 1
Factors Associated with Treatment Prescription to Pulmonary Tuberculosis Contacts in Catalonia (2019–2021): A Population-Based Epidemiological Study
Domı́nguez, Á., Soldevila, N., Toledo, D., Parrón, I., Millet, J.-P., Barrabeig, I., Godoy, P., & on behalf of Transmission of Tuberculosis in Catalonia (Spain) Working Group (2023) · Vaccines · doi:10.3390/vaccines11121800 · Cited by 1
The trial of sending short message service multidrug-resistant tuberculosis patients in Indonesia
Syarifah, S., & Santi, D. N. (2023) · Journal of Public Health in Africa · doi:10.4081/jphia.2023.2675 · Cited by 1
High-volume biological sample processing using microwaves
Wilson-Garner, S., Alzeer, S., Baillie, L. W. J., & Porch, A. (2024) · Journal of Applied Physics · doi:10.1063/5.0178755 · Cited by 1
Switching biologics in psoriasis: Challenges and experience from a small tertiary health-care center
Bojić-Đurović, M., Bojić, M., Popović, A., Golubović, M., & Ražnatović, M. (2024) · SANAMED · doi:10.5937/sanamed0-48793 · Cited by 1
Disseminated MDR-TB missed in a patient treated with TNF inhibitor
Hansen, S. D. H., Rudolf, F., Gregersen, N. S., & Norman, A. (2024) · BMJ Case Reports · doi:10.1136/bcr-2024-260058 · Cited by 1
Diagnosis and treatment of latent tuberculosis infection among household contacts in inland Bahia, Brazil: a cross-sectional follow-up study
Matias, G. L., Sales, M. V. F., Andrade, G., TEIXEIRA, B. D. S., Tenorio, M. E. D. M., Palácio, M. A. V., Correia, M. L. D. C., & Takenami, I. (2024) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2023.0339.r2.03072024 · Cited by 1
Acute Plasmodium yoelii 17XNL Infection During BCG Vaccination Limits T Cell Responses and Mycobacterial Growth Inhibition
Tangie, E., Pinpathomrat, N., Tanner, R., Hsu, N., Spencer, A. J., Jacobs, M., McShane, H., & Keeton, R. S. (2025) · Immunology · doi:10.1111/imm.70006 · Cited by 1
PREDICTING THE RISK OF LOCAL TUBERCULOSIS IN CHILDREN WITH LATENT TUBERCULOSIS INFECTION
Bilogortseva, O., Dotsenko, Y. I., Sivachenko, O., Arefyeva, L. V., Gorbenko, V. V., & Ovsyanitskaya, V. A. (2021) · Ukrainian Pulmonology Journal · doi:10.31215/2306-4927-2021-29-4-5-9 · Cited by 1
A novel nanomicelle composed from PEGylated TB di-peptide could be successfully used as a BCG booster.
Firouzi, Z., Jaafari, M. R., Sankian, M., Zare, S., & Tafaghodi, M. (2022) · PubMed Central · doi:10.22038/ijbms.2022.61373.13583 · Cited by 1

Authors: Cohen, A., Mathiasen, V. D., Schön, T., & Wejse, C.
Affiliations: St Olav's University Hospital (NO)
Linköping University (SE)
Bandim Health Project (GW)
ORCID: Cohen, Adam
Mathiasen, Victor Dahl
Schön, Thomas
Wejse, Christian
Venue: European Respiratory Journal
Publisher: European Respiratory Society (ERS)
Published: 2019-06-20
Volume: 54
Issue: 3
Pages: 1900655
ISSN: 0903-1936 (ISSN-L)
1399-3003
DOI: 10.1183/13993003.00655-2019
OpenAlex: W2950875755
Cited by: 547
References: 123
Citations by year: 2026: 61 · 2025: 78 · 2024: 94 · 2023: 89 · 2022: 101 · 2021: 73 · 2020: 47 · 2019: 4
FWCI: 7.86
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.ersjournals.com/user-licence (vor)
Locations: European Respiratory Journal (publishedVersion)
PubMed (publishedVersion)
Funders: Novo Nordisk (NNF15OC0018034)
Hjärt-Lungfonden (20150236)
Forskningsrådet om Hälsa, Arbetsliv och Välfärd (201602043)
Topics: Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
Keywords: latent tuberculosis infection, global prevalence, interferon-gamma release assay, tuberculin skin test, tuberculosis prophylaxis
MeSH terms: Algorithms, Communicable Disease Control, Humans, Tuberculin Test, Global Health, World Health Organization, Incidence, Prevalence, Latent Tuberculosis, Interferon-gamma Release Tests

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The global prevalence of latent tuberculosis: a systematic review and meta-analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks